Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9396 |
High Similarity |
NPD920 |
Approved |
0.9262 |
High Similarity |
NPD642 |
Clinical (unspecified phase) |
0.9128 |
High Similarity |
NPD643 |
Clinical (unspecified phase) |
0.8926 |
High Similarity |
NPD1243 |
Approved |
0.8688 |
High Similarity |
NPD919 |
Approved |
0.8636 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8608 |
High Similarity |
NPD6801 |
Discontinued |
0.8563 |
High Similarity |
NPD6559 |
Discontinued |
0.8553 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8544 |
High Similarity |
NPD7411 |
Suspended |
0.8509 |
High Similarity |
NPD7075 |
Discontinued |
0.8509 |
High Similarity |
NPD3749 |
Approved |
0.8481 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8477 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8438 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8366 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8354 |
Intermediate Similarity |
NPD1247 |
Approved |
0.8333 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8323 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8301 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8301 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8289 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8282 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.828 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.828 |
Intermediate Similarity |
NPD2534 |
Approved |
0.828 |
Intermediate Similarity |
NPD2532 |
Approved |
0.828 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8235 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.8221 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.8214 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8204 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8194 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8194 |
Intermediate Similarity |
NPD2800 |
Approved |
0.8182 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.816 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8146 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8141 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.8137 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.811 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8072 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8065 |
Intermediate Similarity |
NPD2344 |
Approved |
0.8063 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8059 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8059 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8052 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.8049 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8049 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8039 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8037 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8025 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8013 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8013 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8013 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.8 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7988 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7965 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7953 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7937 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7917 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7911 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7892 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7875 |
Intermediate Similarity |
NPD1511 |
Approved |
0.787 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7862 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7853 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7836 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7821 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7821 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7797 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7791 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7778 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7778 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7778 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7778 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7771 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7771 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7763 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7746 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7742 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7742 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7719 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7718 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7701 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7701 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7682 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7661 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7661 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7657 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7614 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.761 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.758 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7571 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.756 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.756 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7558 |
Intermediate Similarity |
NPD6808 |
Phase 2 |
0.7558 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7557 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7548 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7545 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7533 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7516 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7516 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7514 |
Intermediate Similarity |
NPD4287 |
Approved |
0.75 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.75 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.75 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.75 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7484 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7459 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7456 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7451 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7425 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.741 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7405 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7403 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7401 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.7362 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7351 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7351 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7337 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7325 |
Intermediate Similarity |
NPD411 |
Approved |
0.7325 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7312 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7312 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.731 |
Intermediate Similarity |
NPD2296 |
Approved |
0.7303 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7301 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7301 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7294 |
Intermediate Similarity |
NPD6279 |
Approved |
0.7294 |
Intermediate Similarity |
NPD6280 |
Approved |
0.7294 |
Intermediate Similarity |
NPD37 |
Approved |
0.729 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7284 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7283 |
Intermediate Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7267 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7267 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7267 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7267 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7246 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7239 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7238 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7238 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7233 |
Intermediate Similarity |
NPD943 |
Approved |
0.7233 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7228 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7226 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7226 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7219 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7215 |
Intermediate Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.7215 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7215 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7209 |
Intermediate Similarity |
NPD4288 |
Approved |
0.72 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7191 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7188 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7152 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7151 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7135 |
Intermediate Similarity |
NPD5889 |
Approved |
0.7135 |
Intermediate Similarity |
NPD5890 |
Approved |
0.7133 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7126 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7126 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7115 |
Intermediate Similarity |
NPD1164 |
Approved |
0.7113 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7107 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7093 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7089 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7086 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7081 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7079 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7079 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7079 |
Intermediate Similarity |
NPD4575 |
Clinical (unspecified phase) |
0.7062 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7059 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7041 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7039 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7033 |
Intermediate Similarity |
NPD6764 |
Approved |
0.7033 |
Intermediate Similarity |
NPD6765 |
Approved |
0.7026 |
Intermediate Similarity |
NPD7583 |
Approved |
0.7022 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7012 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7012 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7012 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7012 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7012 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7012 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7012 |
Intermediate Similarity |
NPD4476 |
Approved |
0.7012 |
Intermediate Similarity |
NPD4477 |
Approved |
0.7006 |
Intermediate Similarity |
NPD3887 |
Approved |
0.7 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.699 |
Remote Similarity |
NPD7585 |
Approved |
0.6981 |
Remote Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.6977 |
Remote Similarity |
NPD6585 |
Discontinued |
0.6973 |
Remote Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.697
|
Remote Similarity |
NPD7782 |
Clinical (unspecified phase) |